| Analysis | Metabolite Name | Measured Value | Units | CASE_CONTROL | Chemotherapy | Drug | Race | TIMEPOINT | Tamoxyfen | Taxane |
|---|---|---|---|---|---|---|---|---|---|---|
| Reversed phase POSITIVE ION MODE | METHYL INDOLE-3-ACETATE (CAS# 1912-33-0); (M+H)+ | 1060 | Peak area | Case | Y | Letrozole | White | 3 Month | Y | Y |
| Reversed phase POSITIVE ION MODE | METHYL INDOLE-3-ACETATE (CAS# 1912-33-0); (M+H)+ | 1099 | Peak area | Control | Y | Letrozole | White | Baseline | Y | N |
| Reversed phase POSITIVE ION MODE | METHYL INDOLE-3-ACETATE (CAS# 1912-33-0); (M+H)+ | 1339 | Peak area | Case | Y | Exemestane | White | 3 Month | Y | Y |
| Reversed phase POSITIVE ION MODE | METHYL INDOLE-3-ACETATE (CAS# 1912-33-0); (M+H)+ | 1373 | Peak area | Control | N | Exemestane | White | 3 Month | Y | N |
| Reversed phase POSITIVE ION MODE | METHYL INDOLE-3-ACETATE (CAS# 1912-33-0); (M+H)+ | 1495 | Peak area | Case | Y | Exemestane | White | 3 Month | Y | Y |
| Reversed phase POSITIVE ION MODE | METHYL INDOLE-3-ACETATE (CAS# 1912-33-0); (M+H)+ | 1512 | Peak area | Case | N | Exemestane | White | Baseline | N | N |
| Reversed phase POSITIVE ION MODE | METHYL INDOLE-3-ACETATE (CAS# 1912-33-0); (M+H)+ | 1956 | Peak area | Control | Y | Exemestane | White | Baseline | N | Y |
| Reversed phase POSITIVE ION MODE | METHYL INDOLE-3-ACETATE (CAS# 1912-33-0); (M+H)+ | 2244 | Peak area | Control | N | Exemestane | White | Baseline | N | N |
| Reversed phase POSITIVE ION MODE | METHYL INDOLE-3-ACETATE (CAS# 1912-33-0); (M+H)+ | 2426 | Peak area | Case | Y | Exemestane | White | Baseline | N | Y |
| Reversed phase POSITIVE ION MODE | METHYL INDOLE-3-ACETATE (CAS# 1912-33-0); (M+H)+ | 2557 | Peak area | Control | Y | Letrozole | White | 3 Month | Y | Y |
| Reversed phase POSITIVE ION MODE | METHYL INDOLE-3-ACETATE (CAS# 1912-33-0); (M+H)+ | 2765 | Peak area | Control | N | Letrozole | Black | Baseline | N | N |
| Reversed phase POSITIVE ION MODE | METHYL INDOLE-3-ACETATE (CAS# 1912-33-0); (M+H)+ | 2793 | Peak area | Case | N | Letrozole | White | Baseline | Y | N |
| Reversed phase POSITIVE ION MODE | METHYL INDOLE-3-ACETATE (CAS# 1912-33-0); (M+H)+ | 2896 | Peak area | Case | N | Exemestane | White | Baseline | Y | N |
| Reversed phase POSITIVE ION MODE | METHYL INDOLE-3-ACETATE (CAS# 1912-33-0); (M+H)+ | 3086 | Peak area | Case | N | Exemestane | White | 3 Month | N | N |
| Reversed phase POSITIVE ION MODE | METHYL INDOLE-3-ACETATE (CAS# 1912-33-0); (M+H)+ | 3263 | Peak area | Case | Y | Exemestane | White | 3 Month | N | Y |
| Reversed phase POSITIVE ION MODE | METHYL INDOLE-3-ACETATE (CAS# 1912-33-0); (M+H)+ | 3425 | Peak area | Case | N | Exemestane | White | 3 Month | Y | N |
| Reversed phase POSITIVE ION MODE | METHYL INDOLE-3-ACETATE (CAS# 1912-33-0); (M+H)+ | 3439 | Peak area | Control | Y | Exemestane | White | 3 Month | Y | N |
| Reversed phase POSITIVE ION MODE | METHYL INDOLE-3-ACETATE (CAS# 1912-33-0); (M+H)+ | 3756 | Peak area | Case | N | Exemestane | White | 3 Month | N | N |
| Reversed phase POSITIVE ION MODE | METHYL INDOLE-3-ACETATE (CAS# 1912-33-0); (M+H)+ | 3778 | Peak area | Case | N | Letrozole | White | 3 Month | N | N |
| Reversed phase POSITIVE ION MODE | METHYL INDOLE-3-ACETATE (CAS# 1912-33-0); (M+H)+ | 3855 | Peak area | Control | N | Letrozole | White | Baseline | N | N |
| Reversed phase POSITIVE ION MODE | METHYL INDOLE-3-ACETATE (CAS# 1912-33-0); (M+H)+ | 4177 | Peak area | Case | Y | Exemestane | White | Baseline | N | Y |
| Reversed phase POSITIVE ION MODE | METHYL INDOLE-3-ACETATE (CAS# 1912-33-0); (M+H)+ | 4357 | Peak area | Case | Y | Exemestane | White | Baseline | Y | N |
| Reversed phase POSITIVE ION MODE | METHYL INDOLE-3-ACETATE (CAS# 1912-33-0); (M+H)+ | 4380 | Peak area | Control | N | Letrozole | Black | 3 Month | N | N |
| Reversed phase POSITIVE ION MODE | METHYL INDOLE-3-ACETATE (CAS# 1912-33-0); (M+H)+ | 4653 | Peak area | Case | Y | Exemestane | White | Baseline | Y | N |
| Reversed phase POSITIVE ION MODE | METHYL INDOLE-3-ACETATE (CAS# 1912-33-0); (M+H)+ | 5014 | Peak area | Case | N | Letrozole | White | 3 Month | N | N |
| Reversed phase POSITIVE ION MODE | METHYL INDOLE-3-ACETATE (CAS# 1912-33-0); (M+H)+ | 5201 | Peak area | Case | Y | Exemestane | White | Baseline | Y | Y |
| Reversed phase POSITIVE ION MODE | METHYL INDOLE-3-ACETATE (CAS# 1912-33-0); (M+H)+ | 5573 | Peak area | Control | N | Letrozole | White | 3 Month | N | N |
| Reversed phase POSITIVE ION MODE | METHYL INDOLE-3-ACETATE (CAS# 1912-33-0); (M+H)+ | 5609 | Peak area | Control | Y | Letrozole | White | Baseline | Y | Y |
| Reversed phase POSITIVE ION MODE | METHYL INDOLE-3-ACETATE (CAS# 1912-33-0); (M+H)+ | 7016 | Peak area | Case | N | Letrozole | Black | 3 Month | N | N |
| Reversed phase POSITIVE ION MODE | METHYL INDOLE-3-ACETATE (CAS# 1912-33-0); (M+H)+ | 9286 | Peak area | Case | N | Exemestane | White | Baseline | Y | N |
| Reversed phase POSITIVE ION MODE | METHYL INDOLE-3-ACETATE (CAS# 1912-33-0); (M+H)+ | 12606 | Peak area | Case | N | Letrozole | Black | Baseline | N | N |
| Reversed phase POSITIVE ION MODE | METHYL INDOLE-3-ACETATE (CAS# 1912-33-0); (M+H)+ | Peak area | Case | N | Exemestane | Black | 3 Month | N | N | |
| Reversed phase POSITIVE ION MODE | METHYL INDOLE-3-ACETATE (CAS# 1912-33-0); (M+H)+ | Peak area | Case | N | Exemestane | Black | Baseline | N | N | |
| Reversed phase POSITIVE ION MODE | METHYL INDOLE-3-ACETATE (CAS# 1912-33-0); (M+H)+ | Peak area | Case | N | Exemestane | White | 3 Month | N | N | |
| Reversed phase POSITIVE ION MODE | METHYL INDOLE-3-ACETATE (CAS# 1912-33-0); (M+H)+ | Peak area | Case | N | Exemestane | White | 3 Month | Y | N | |
| Reversed phase POSITIVE ION MODE | METHYL INDOLE-3-ACETATE (CAS# 1912-33-0); (M+H)+ | Peak area | Case | N | Exemestane | White | Baseline | N | N | |
| Reversed phase POSITIVE ION MODE | METHYL INDOLE-3-ACETATE (CAS# 1912-33-0); (M+H)+ | Peak area | Case | N | Exemestane | White | Baseline | Y | N | |
| Reversed phase POSITIVE ION MODE | METHYL INDOLE-3-ACETATE (CAS# 1912-33-0); (M+H)+ | Peak area | Case | N | Letrozole | White | 3 Month | Y | N | |
| Reversed phase POSITIVE ION MODE | METHYL INDOLE-3-ACETATE (CAS# 1912-33-0); (M+H)+ | Peak area | Case | N | Letrozole | White | Baseline | N | N | |
| Reversed phase POSITIVE ION MODE | METHYL INDOLE-3-ACETATE (CAS# 1912-33-0); (M+H)+ | Peak area | Case | N | Letrozole | White | Baseline | Y | N | |
| Reversed phase POSITIVE ION MODE | METHYL INDOLE-3-ACETATE (CAS# 1912-33-0); (M+H)+ | Peak area | Case | Y | Exemestane | Black | 3 Month | N | Y | |
| Reversed phase POSITIVE ION MODE | METHYL INDOLE-3-ACETATE (CAS# 1912-33-0); (M+H)+ | Peak area | Case | Y | Exemestane | Black | Baseline | N | Y | |
| Reversed phase POSITIVE ION MODE | METHYL INDOLE-3-ACETATE (CAS# 1912-33-0); (M+H)+ | Peak area | Case | Y | Exemestane | White | 3 Month | N | Y | |
| Reversed phase POSITIVE ION MODE | METHYL INDOLE-3-ACETATE (CAS# 1912-33-0); (M+H)+ | Peak area | Case | Y | Exemestane | White | 3 Month | Y | N | |
| Reversed phase POSITIVE ION MODE | METHYL INDOLE-3-ACETATE (CAS# 1912-33-0); (M+H)+ | Peak area | Case | Y | Exemestane | White | Baseline | N | Y | |
| Reversed phase POSITIVE ION MODE | METHYL INDOLE-3-ACETATE (CAS# 1912-33-0); (M+H)+ | Peak area | Case | Y | Exemestane | White | Baseline | Y | Y | |
| Reversed phase POSITIVE ION MODE | METHYL INDOLE-3-ACETATE (CAS# 1912-33-0); (M+H)+ | Peak area | Case | Y | Letrozole | White | 3 Month | Y | Y | |
| Reversed phase POSITIVE ION MODE | METHYL INDOLE-3-ACETATE (CAS# 1912-33-0); (M+H)+ | Peak area | Case | Y | Letrozole | White | Baseline | Y | Y | |
| Reversed phase POSITIVE ION MODE | METHYL INDOLE-3-ACETATE (CAS# 1912-33-0); (M+H)+ | Peak area | Control | N | Exemestane | Black | 3 Month | Y | N | |
| Reversed phase POSITIVE ION MODE | METHYL INDOLE-3-ACETATE (CAS# 1912-33-0); (M+H)+ | Peak area | Control | N | Exemestane | Black | Baseline | Y | N | |
| Reversed phase POSITIVE ION MODE | METHYL INDOLE-3-ACETATE (CAS# 1912-33-0); (M+H)+ | Peak area | Control | N | Exemestane | White | 3 Month | N | N | |
| Reversed phase POSITIVE ION MODE | METHYL INDOLE-3-ACETATE (CAS# 1912-33-0); (M+H)+ | Peak area | Control | N | Exemestane | White | Baseline | N | N | |
| Reversed phase POSITIVE ION MODE | METHYL INDOLE-3-ACETATE (CAS# 1912-33-0); (M+H)+ | Peak area | Control | N | Exemestane | White | Baseline | Y | N | |
| Reversed phase POSITIVE ION MODE | METHYL INDOLE-3-ACETATE (CAS# 1912-33-0); (M+H)+ | Peak area | Control | N | Letrozole | White | 3 Month | N | N | |
| Reversed phase POSITIVE ION MODE | METHYL INDOLE-3-ACETATE (CAS# 1912-33-0); (M+H)+ | Peak area | Control | N | Letrozole | White | 3 Month | Y | N | |
| Reversed phase POSITIVE ION MODE | METHYL INDOLE-3-ACETATE (CAS# 1912-33-0); (M+H)+ | Peak area | Control | N | Letrozole | White | Baseline | N | N | |
| Reversed phase POSITIVE ION MODE | METHYL INDOLE-3-ACETATE (CAS# 1912-33-0); (M+H)+ | Peak area | Control | N | Letrozole | White | Baseline | Y | N | |
| Reversed phase POSITIVE ION MODE | METHYL INDOLE-3-ACETATE (CAS# 1912-33-0); (M+H)+ | Peak area | Control | Y | Exemestane | White | 3 Month | N | N | |
| Reversed phase POSITIVE ION MODE | METHYL INDOLE-3-ACETATE (CAS# 1912-33-0); (M+H)+ | Peak area | Control | Y | Exemestane | White | 3 Month | N | Y | |
| Reversed phase POSITIVE ION MODE | METHYL INDOLE-3-ACETATE (CAS# 1912-33-0); (M+H)+ | Peak area | Control | Y | Exemestane | White | 3 Month | Y | N | |
| Reversed phase POSITIVE ION MODE | METHYL INDOLE-3-ACETATE (CAS# 1912-33-0); (M+H)+ | Peak area | Control | Y | Exemestane | White | 3 Month | Y | Y | |
| Reversed phase POSITIVE ION MODE | METHYL INDOLE-3-ACETATE (CAS# 1912-33-0); (M+H)+ | Peak area | Control | Y | Exemestane | White | Baseline | N | N | |
| Reversed phase POSITIVE ION MODE | METHYL INDOLE-3-ACETATE (CAS# 1912-33-0); (M+H)+ | Peak area | Control | Y | Exemestane | White | Baseline | N | Y | |
| Reversed phase POSITIVE ION MODE | METHYL INDOLE-3-ACETATE (CAS# 1912-33-0); (M+H)+ | Peak area | Control | Y | Exemestane | White | Baseline | Y | N | |
| Reversed phase POSITIVE ION MODE | METHYL INDOLE-3-ACETATE (CAS# 1912-33-0); (M+H)+ | Peak area | Control | Y | Exemestane | White | Baseline | Y | Y | |
| Reversed phase POSITIVE ION MODE | METHYL INDOLE-3-ACETATE (CAS# 1912-33-0); (M+H)+ | Peak area | Control | Y | Letrozole | White | 3 Month | Y | N | |
| Reversed phase POSITIVE ION MODE | METHYL INDOLE-3-ACETATE (CAS# 1912-33-0); (M+H)+ | Peak area | Control | Y | Letrozole | White | 3 Month | Y | Y | |
| Reversed phase POSITIVE ION MODE | METHYL INDOLE-3-ACETATE (CAS# 1912-33-0); (M+H)+ | Peak area | Control | Y | Letrozole | White | Baseline | Y | Y | |
| Reversed phase POSITIVE ION MODE | METHYL INDOLE-3-ACETATE (CAS# 1912-33-0); (M+NA)+ | 4596 | Peak area | Control | Y | Exemestane | White | 3 Month | Y | N |
| Reversed phase POSITIVE ION MODE | METHYL INDOLE-3-ACETATE (CAS# 1912-33-0); (M+NA)+ | 4715 | Peak area | Case | N | Letrozole | White | 3 Month | Y | N |
| Reversed phase POSITIVE ION MODE | METHYL INDOLE-3-ACETATE (CAS# 1912-33-0); (M+NA)+ | 4913 | Peak area | Control | Y | Exemestane | White | Baseline | N | Y |
| Reversed phase POSITIVE ION MODE | METHYL INDOLE-3-ACETATE (CAS# 1912-33-0); (M+NA)+ | 5213 | Peak area | Case | Y | Exemestane | White | 3 Month | N | Y |
| Reversed phase POSITIVE ION MODE | METHYL INDOLE-3-ACETATE (CAS# 1912-33-0); (M+NA)+ | 6085 | Peak area | Case | Y | Exemestane | White | 3 Month | N | Y |
| Reversed phase POSITIVE ION MODE | METHYL INDOLE-3-ACETATE (CAS# 1912-33-0); (M+NA)+ | 6537 | Peak area | Control | Y | Exemestane | White | Baseline | Y | N |
| Reversed phase POSITIVE ION MODE | METHYL INDOLE-3-ACETATE (CAS# 1912-33-0); (M+NA)+ | 6914 | Peak area | Case | N | Exemestane | White | Baseline | N | N |
| Reversed phase POSITIVE ION MODE | METHYL INDOLE-3-ACETATE (CAS# 1912-33-0); (M+NA)+ | 7241 | Peak area | Control | N | Exemestane | White | Baseline | N | N |
| Reversed phase POSITIVE ION MODE | METHYL INDOLE-3-ACETATE (CAS# 1912-33-0); (M+NA)+ | 7493 | Peak area | Control | N | Letrozole | White | 3 Month | Y | N |
| Reversed phase POSITIVE ION MODE | METHYL INDOLE-3-ACETATE (CAS# 1912-33-0); (M+NA)+ | 7811 | Peak area | Control | Y | Letrozole | White | Baseline | Y | N |
| Reversed phase POSITIVE ION MODE | METHYL INDOLE-3-ACETATE (CAS# 1912-33-0); (M+NA)+ | 7875 | Peak area | Control | Y | Exemestane | White | Baseline | N | N |
| Reversed phase POSITIVE ION MODE | METHYL INDOLE-3-ACETATE (CAS# 1912-33-0); (M+NA)+ | 8181 | Peak area | Control | N | Exemestane | White | Baseline | N | N |
| Reversed phase POSITIVE ION MODE | METHYL INDOLE-3-ACETATE (CAS# 1912-33-0); (M+NA)+ | 8578 | Peak area | Case | Y | Letrozole | White | 3 Month | Y | Y |
| Reversed phase POSITIVE ION MODE | METHYL INDOLE-3-ACETATE (CAS# 1912-33-0); (M+NA)+ | 8714 | Peak area | Case | N | Exemestane | White | Baseline | N | N |
| Reversed phase POSITIVE ION MODE | METHYL INDOLE-3-ACETATE (CAS# 1912-33-0); (M+NA)+ | 8837 | Peak area | Control | Y | Exemestane | White | Baseline | Y | N |
| Reversed phase POSITIVE ION MODE | METHYL INDOLE-3-ACETATE (CAS# 1912-33-0); (M+NA)+ | 8896 | Peak area | Case | Y | Exemestane | White | 3 Month | Y | Y |
| Reversed phase POSITIVE ION MODE | METHYL INDOLE-3-ACETATE (CAS# 1912-33-0); (M+NA)+ | 8981 | Peak area | Control | Y | Exemestane | White | 3 Month | Y | N |
| Reversed phase POSITIVE ION MODE | METHYL INDOLE-3-ACETATE (CAS# 1912-33-0); (M+NA)+ | 9013 | Peak area | Case | Y | Letrozole | White | 3 Month | Y | Y |
| Reversed phase POSITIVE ION MODE | METHYL INDOLE-3-ACETATE (CAS# 1912-33-0); (M+NA)+ | 9680 | Peak area | Case | Y | Exemestane | White | Baseline | N | Y |
| Reversed phase POSITIVE ION MODE | METHYL INDOLE-3-ACETATE (CAS# 1912-33-0); (M+NA)+ | 10063 | Peak area | Control | Y | Exemestane | White | Baseline | Y | N |
| Reversed phase POSITIVE ION MODE | METHYL INDOLE-3-ACETATE (CAS# 1912-33-0); (M+NA)+ | 10096 | Peak area | Control | Y | Exemestane | White | 3 Month | N | Y |
| Reversed phase POSITIVE ION MODE | METHYL INDOLE-3-ACETATE (CAS# 1912-33-0); (M+NA)+ | 10131 | Peak area | Control | Y | Exemestane | White | Baseline | Y | Y |
| Reversed phase POSITIVE ION MODE | METHYL INDOLE-3-ACETATE (CAS# 1912-33-0); (M+NA)+ | 10148 | Peak area | Control | N | Exemestane | White | 3 Month | Y | N |
| Reversed phase POSITIVE ION MODE | METHYL INDOLE-3-ACETATE (CAS# 1912-33-0); (M+NA)+ | 10254 | Peak area | Case | N | Letrozole | White | 3 Month | Y | N |
| Reversed phase POSITIVE ION MODE | METHYL INDOLE-3-ACETATE (CAS# 1912-33-0); (M+NA)+ | 10288 | Peak area | Control | N | Letrozole | White | 3 Month | Y | N |
| Reversed phase POSITIVE ION MODE | METHYL INDOLE-3-ACETATE (CAS# 1912-33-0); (M+NA)+ | 10444 | Peak area | Case | Y | Letrozole | White | Baseline | Y | Y |
| Reversed phase POSITIVE ION MODE | METHYL INDOLE-3-ACETATE (CAS# 1912-33-0); (M+NA)+ | 10663 | Peak area | Case | N | Letrozole | White | Baseline | Y | N |
| Reversed phase POSITIVE ION MODE | METHYL INDOLE-3-ACETATE (CAS# 1912-33-0); (M+NA)+ | 10840 | Peak area | Control | N | Exemestane | White | Baseline | N | N |
| Reversed phase POSITIVE ION MODE | METHYL INDOLE-3-ACETATE (CAS# 1912-33-0); (M+NA)+ | 11244 | Peak area | Control | N | Letrozole | White | Baseline | Y | N |
| Reversed phase POSITIVE ION MODE | METHYL INDOLE-3-ACETATE (CAS# 1912-33-0); (M+NA)+ | 11594 | Peak area | Control | Y | Exemestane | White | 3 Month | N | Y |
| Reversed phase POSITIVE ION MODE | METHYL INDOLE-3-ACETATE (CAS# 1912-33-0); (M+NA)+ | 11740 | Peak area | Control | Y | Exemestane | White | Baseline | N | N |
| Reversed phase POSITIVE ION MODE | METHYL INDOLE-3-ACETATE (CAS# 1912-33-0); (M+NA)+ | 11794 | Peak area | Control | Y | Letrozole | White | Baseline | Y | Y |
| Reversed phase POSITIVE ION MODE | METHYL INDOLE-3-ACETATE (CAS# 1912-33-0); (M+NA)+ | 11984 | Peak area | Control | N | Exemestane | Black | Baseline | Y | N |
| Reversed phase POSITIVE ION MODE | METHYL INDOLE-3-ACETATE (CAS# 1912-33-0); (M+NA)+ | 12016 | Peak area | Case | Y | Exemestane | White | 3 Month | Y | Y |
| Reversed phase POSITIVE ION MODE | METHYL INDOLE-3-ACETATE (CAS# 1912-33-0); (M+NA)+ | 12065 | Peak area | Case | Y | Exemestane | White | 3 Month | N | Y |
| Reversed phase POSITIVE ION MODE | METHYL INDOLE-3-ACETATE (CAS# 1912-33-0); (M+NA)+ | 12162 | Peak area | Control | N | Exemestane | White | Baseline | Y | N |
| Reversed phase POSITIVE ION MODE | METHYL INDOLE-3-ACETATE (CAS# 1912-33-0); (M+NA)+ | 12168 | Peak area | Control | N | Letrozole | White | 3 Month | N | N |
| Reversed phase POSITIVE ION MODE | METHYL INDOLE-3-ACETATE (CAS# 1912-33-0); (M+NA)+ | 12172 | Peak area | Control | N | Exemestane | White | Baseline | N | N |
| Reversed phase POSITIVE ION MODE | METHYL INDOLE-3-ACETATE (CAS# 1912-33-0); (M+NA)+ | 12220 | Peak area | Case | N | Exemestane | White | 3 Month | N | N |
| Reversed phase POSITIVE ION MODE | METHYL INDOLE-3-ACETATE (CAS# 1912-33-0); (M+NA)+ | 12285 | Peak area | Control | N | Exemestane | White | 3 Month | N | N |
| Reversed phase POSITIVE ION MODE | METHYL INDOLE-3-ACETATE (CAS# 1912-33-0); (M+NA)+ | 12419 | Peak area | Control | Y | Exemestane | White | Baseline | N | Y |
| Reversed phase POSITIVE ION MODE | METHYL INDOLE-3-ACETATE (CAS# 1912-33-0); (M+NA)+ | 12624 | Peak area | Control | Y | Exemestane | White | 3 Month | N | N |
| Reversed phase POSITIVE ION MODE | METHYL INDOLE-3-ACETATE (CAS# 1912-33-0); (M+NA)+ | 12859 | Peak area | Case | Y | Exemestane | White | 3 Month | Y | N |
| Reversed phase POSITIVE ION MODE | METHYL INDOLE-3-ACETATE (CAS# 1912-33-0); (M+NA)+ | 12884 | Peak area | Case | Y | Letrozole | White | 3 Month | Y | Y |
| Reversed phase POSITIVE ION MODE | METHYL INDOLE-3-ACETATE (CAS# 1912-33-0); (M+NA)+ | 12969 | Peak area | Control | N | Letrozole | White | Baseline | Y | N |
| Reversed phase POSITIVE ION MODE | METHYL INDOLE-3-ACETATE (CAS# 1912-33-0); (M+NA)+ | 12987 | Peak area | Control | N | Exemestane | White | Baseline | N | N |
| Reversed phase POSITIVE ION MODE | METHYL INDOLE-3-ACETATE (CAS# 1912-33-0); (M+NA)+ | 13221 | Peak area | Control | N | Exemestane | Black | 3 Month | Y | N |
| Reversed phase POSITIVE ION MODE | METHYL INDOLE-3-ACETATE (CAS# 1912-33-0); (M+NA)+ | 13368 | Peak area | Control | N | Exemestane | White | 3 Month | N | N |
| Reversed phase POSITIVE ION MODE | METHYL INDOLE-3-ACETATE (CAS# 1912-33-0); (M+NA)+ | 13686 | Peak area | Case | N | Exemestane | White | Baseline | Y | N |
| Reversed phase POSITIVE ION MODE | METHYL INDOLE-3-ACETATE (CAS# 1912-33-0); (M+NA)+ | 13821 | Peak area | Control | Y | Exemestane | White | 3 Month | Y | N |
| Reversed phase POSITIVE ION MODE | METHYL INDOLE-3-ACETATE (CAS# 1912-33-0); (M+NA)+ | 13901 | Peak area | Case | Y | Exemestane | White | Baseline | Y | Y |
| Reversed phase POSITIVE ION MODE | METHYL INDOLE-3-ACETATE (CAS# 1912-33-0); (M+NA)+ | 13916 | Peak area | Control | Y | Exemestane | White | 3 Month | Y | Y |
| Reversed phase POSITIVE ION MODE | METHYL INDOLE-3-ACETATE (CAS# 1912-33-0); (M+NA)+ | 14075 | Peak area | Case | Y | Exemestane | White | 3 Month | N | Y |
| Reversed phase POSITIVE ION MODE | METHYL INDOLE-3-ACETATE (CAS# 1912-33-0); (M+NA)+ | 14129 | Peak area | Case | Y | Letrozole | White | Baseline | Y | Y |
| Reversed phase POSITIVE ION MODE | METHYL INDOLE-3-ACETATE (CAS# 1912-33-0); (M+NA)+ | 14245 | Peak area | Case | N | Letrozole | White | Baseline | N | N |
| Reversed phase POSITIVE ION MODE | METHYL INDOLE-3-ACETATE (CAS# 1912-33-0); (M+NA)+ | 14567 | Peak area | Control | Y | Letrozole | White | 3 Month | Y | Y |
| Reversed phase POSITIVE ION MODE | METHYL INDOLE-3-ACETATE (CAS# 1912-33-0); (M+NA)+ | 14819 | Peak area | Control | Y | Letrozole | White | 3 Month | Y | Y |
| Reversed phase POSITIVE ION MODE | METHYL INDOLE-3-ACETATE (CAS# 1912-33-0); (M+NA)+ | 14911 | Peak area | Control | N | Letrozole | White | 3 Month | Y | N |
| Reversed phase POSITIVE ION MODE | METHYL INDOLE-3-ACETATE (CAS# 1912-33-0); (M+NA)+ | 15317 | Peak area | Case | N | Exemestane | White | 3 Month | N | N |
| Reversed phase POSITIVE ION MODE | METHYL INDOLE-3-ACETATE (CAS# 1912-33-0); (M+NA)+ | 15742 | Peak area | Case | Y | Exemestane | White | Baseline | N | Y |
| Reversed phase POSITIVE ION MODE | METHYL INDOLE-3-ACETATE (CAS# 1912-33-0); (M+NA)+ | 15769 | Peak area | Control | Y | Letrozole | White | 3 Month | Y | N |
| Reversed phase POSITIVE ION MODE | METHYL INDOLE-3-ACETATE (CAS# 1912-33-0); (M+NA)+ | 16837 | Peak area | Control | Y | Exemestane | White | 3 Month | N | N |
| Reversed phase POSITIVE ION MODE | METHYL INDOLE-3-ACETATE (CAS# 1912-33-0); (M+NA)+ | 17259 | Peak area | Case | Y | Exemestane | White | Baseline | N | Y |
| Reversed phase POSITIVE ION MODE | METHYL INDOLE-3-ACETATE (CAS# 1912-33-0); (M+NA)+ | 17293 | Peak area | Case | N | Letrozole | White | Baseline | N | N |
| Reversed phase POSITIVE ION MODE | METHYL INDOLE-3-ACETATE (CAS# 1912-33-0); (M+NA)+ | 17372 | Peak area | Case | N | Letrozole | White | Baseline | Y | N |
| Reversed phase POSITIVE ION MODE | METHYL INDOLE-3-ACETATE (CAS# 1912-33-0); (M+NA)+ | 17772 | Peak area | Case | N | Exemestane | White | 3 Month | Y | N |
| Reversed phase POSITIVE ION MODE | METHYL INDOLE-3-ACETATE (CAS# 1912-33-0); (M+NA)+ | 17882 | Peak area | Case | N | Exemestane | White | Baseline | N | N |
| Reversed phase POSITIVE ION MODE | METHYL INDOLE-3-ACETATE (CAS# 1912-33-0); (M+NA)+ | 18457 | Peak area | Case | N | Exemestane | White | 3 Month | N | N |
| Reversed phase POSITIVE ION MODE | METHYL INDOLE-3-ACETATE (CAS# 1912-33-0); (M+NA)+ | 18754 | Peak area | Control | N | Exemestane | White | 3 Month | N | N |
| Reversed phase POSITIVE ION MODE | METHYL INDOLE-3-ACETATE (CAS# 1912-33-0); (M+NA)+ | 19669 | Peak area | Control | N | Letrozole | Black | Baseline | N | N |
| Reversed phase POSITIVE ION MODE | METHYL INDOLE-3-ACETATE (CAS# 1912-33-0); (M+NA)+ | 19759 | Peak area | Case | Y | Exemestane | Black | 3 Month | N | Y |
| Reversed phase POSITIVE ION MODE | METHYL INDOLE-3-ACETATE (CAS# 1912-33-0); (M+NA)+ | 20592 | Peak area | Control | N | Letrozole | White | Baseline | Y | N |
| Reversed phase POSITIVE ION MODE | METHYL INDOLE-3-ACETATE (CAS# 1912-33-0); (M+NA)+ | 21604 | Peak area | Case | N | Exemestane | Black | 3 Month | N | N |
| Reversed phase POSITIVE ION MODE | METHYL INDOLE-3-ACETATE (CAS# 1912-33-0); (M+NA)+ | 21836 | Peak area | Control | N | Letrozole | White | Baseline | N | N |
| Reversed phase POSITIVE ION MODE | METHYL INDOLE-3-ACETATE (CAS# 1912-33-0); (M+NA)+ | 21839 | Peak area | Case | N | Letrozole | White | 3 Month | Y | N |
| Reversed phase POSITIVE ION MODE | METHYL INDOLE-3-ACETATE (CAS# 1912-33-0); (M+NA)+ | 22187 | Peak area | Control | N | Letrozole | Black | 3 Month | N | N |
| Reversed phase POSITIVE ION MODE | METHYL INDOLE-3-ACETATE (CAS# 1912-33-0); (M+NA)+ | 22310 | Peak area | Control | N | Letrozole | White | Baseline | N | N |
| Reversed phase POSITIVE ION MODE | METHYL INDOLE-3-ACETATE (CAS# 1912-33-0); (M+NA)+ | 22896 | Peak area | Case | Y | Exemestane | White | 3 Month | Y | N |
| Reversed phase POSITIVE ION MODE | METHYL INDOLE-3-ACETATE (CAS# 1912-33-0); (M+NA)+ | 22995 | Peak area | Case | N | Letrozole | White | Baseline | Y | N |
| Reversed phase POSITIVE ION MODE | METHYL INDOLE-3-ACETATE (CAS# 1912-33-0); (M+NA)+ | 22998 | Peak area | Case | Y | Exemestane | White | Baseline | Y | N |
| Reversed phase POSITIVE ION MODE | METHYL INDOLE-3-ACETATE (CAS# 1912-33-0); (M+NA)+ | 23160 | Peak area | Case | Y | Exemestane | White | Baseline | Y | N |
| Reversed phase POSITIVE ION MODE | METHYL INDOLE-3-ACETATE (CAS# 1912-33-0); (M+NA)+ | 23690 | Peak area | Case | N | Exemestane | White | Baseline | Y | N |
| Reversed phase POSITIVE ION MODE | METHYL INDOLE-3-ACETATE (CAS# 1912-33-0); (M+NA)+ | 23754 | Peak area | Case | Y | Exemestane | White | Baseline | Y | Y |
| Reversed phase POSITIVE ION MODE | METHYL INDOLE-3-ACETATE (CAS# 1912-33-0); (M+NA)+ | 24187 | Peak area | Case | N | Exemestane | White | 3 Month | Y | N |
| Reversed phase POSITIVE ION MODE | METHYL INDOLE-3-ACETATE (CAS# 1912-33-0); (M+NA)+ | 24257 | Peak area | Case | Y | Exemestane | White | Baseline | N | Y |
| Reversed phase POSITIVE ION MODE | METHYL INDOLE-3-ACETATE (CAS# 1912-33-0); (M+NA)+ | 25936 | Peak area | Case | N | Letrozole | White | 3 Month | N | N |
| Reversed phase POSITIVE ION MODE | METHYL INDOLE-3-ACETATE (CAS# 1912-33-0); (M+NA)+ | 27012 | Peak area | Case | Y | Exemestane | Black | Baseline | N | Y |
| Reversed phase POSITIVE ION MODE | METHYL INDOLE-3-ACETATE (CAS# 1912-33-0); (M+NA)+ | 27024 | Peak area | Control | N | Letrozole | White | 3 Month | N | N |
| Reversed phase POSITIVE ION MODE | METHYL INDOLE-3-ACETATE (CAS# 1912-33-0); (M+NA)+ | 28683 | Peak area | Case | N | Letrozole | White | 3 Month | N | N |
| Reversed phase POSITIVE ION MODE | METHYL INDOLE-3-ACETATE (CAS# 1912-33-0); (M+NA)+ | 28687 | Peak area | Case | Y | Letrozole | White | Baseline | Y | Y |
| Reversed phase POSITIVE ION MODE | METHYL INDOLE-3-ACETATE (CAS# 1912-33-0); (M+NA)+ | 34760 | Peak area | Control | N | Letrozole | White | 3 Month | N | N |
| Reversed phase POSITIVE ION MODE | METHYL INDOLE-3-ACETATE (CAS# 1912-33-0); (M+NA)+ | 41884 | Peak area | Control | N | Letrozole | White | Baseline | N | N |
| Reversed phase POSITIVE ION MODE | METHYL INDOLE-3-ACETATE (CAS# 1912-33-0); (M+NA)+ | 43471 | Peak area | Control | Y | Letrozole | White | Baseline | Y | Y |
| Reversed phase POSITIVE ION MODE | METHYL INDOLE-3-ACETATE (CAS# 1912-33-0); (M+NA)+ | 44842 | Peak area | Case | N | Letrozole | Black | 3 Month | N | N |
| Reversed phase POSITIVE ION MODE | METHYL INDOLE-3-ACETATE (CAS# 1912-33-0); (M+NA)+ | 52503 | Peak area | Case | N | Exemestane | Black | Baseline | N | N |
| Reversed phase POSITIVE ION MODE | METHYL INDOLE-3-ACETATE (CAS# 1912-33-0); (M+NA)+ | 57616 | Peak area | Case | N | Exemestane | White | Baseline | Y | N |
| Reversed phase POSITIVE ION MODE | METHYL INDOLE-3-ACETATE (CAS# 1912-33-0); (M+NA)+ | 58686 | Peak area | Case | N | Letrozole | Black | Baseline | N | N |
| Reversed phase POSITIVE ION MODE | METHYL INDOLE-3-ACETATE (CAS# 1912-33-0); (M+NA)+ | 64260 | Peak area | Control | N | Exemestane | White | 3 Month | N | N |
| Reversed phase POSITIVE ION MODE | METHYL INDOLE-3-ACETATE (CAS# 1912-33-0); (M+NA)+ | Peak area | Case | N | Exemestane | White | 3 Month | Y | N | |
| Reversed phase POSITIVE ION MODE | METHYL INDOLE-3-ACETATE (CAS# 1912-33-0); (M+NA)+ | Peak area | Control | N | Exemestane | White | 3 Month | N | N |
- UCSD Metabolomics Workbench, a resource sponsored by the Common Fund of the National Institutes of Health
|